183 related articles for article (PubMed ID: 23640227)
1. 68Ga-DOTANOC somatostatin receptor PET-CT imaging in multiple myeloma.
Sharma P; Dhull VS; Suman S; Bal C; Malhotra A; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):374-5. PubMed ID: 23640227
[TBL] [Abstract][Full Text] [Related]
2. Metastatic neuroendocrine carcinoma presenting as a "Superscan" on 68Ga-DOTANOC somatostatin receptor PET/CT.
Naswa N; Karunanithi S; Soundararajan R; Das KJ; Agarwal KK; Malhotra A; Bal C; Kumar R
Clin Nucl Med; 2012 Sep; 37(9):892-4. PubMed ID: 22889781
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-DOTANOC PET-CT demonstrating in vivo somatostatin receptor expression in idiopathic gynecomastia.
Dhull VS; Sharma P; Singla S; Singhal A; Bal C; Kumar R
Clin Nucl Med; 2013 Aug; 38(8):e324-5. PubMed ID: 23531768
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-DOTANOC PET/CT in Adrenal Schwannoma.
Aggarwal P; Singh H; Kumar R; Nada R; Bora GS; Walia R
Clin Nucl Med; 2023 Jan; 48(1):e22-e23. PubMed ID: 36469076
[TBL] [Abstract][Full Text] [Related]
6. 68Ga DOTANOC PET/CT in primary neuroendocrine tumor of the breast.
Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):396-8. PubMed ID: 24566407
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma.
Sharma P; Arora S; Karunanithi S; Khadgawat R; Durgapal P; Sharma R; Kandasamy D; Bal C; Kumar R
Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):69-76. PubMed ID: 24740163
[TBL] [Abstract][Full Text] [Related]
8. Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT.
Treglia G; Cardillo G; Stefanelli A; Di Franco D; Enang GN; Giordano A; Rufini V
Clin Nucl Med; 2013 Dec; 38(12):e458-62. PubMed ID: 23486329
[TBL] [Abstract][Full Text] [Related]
9. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
[TBL] [Abstract][Full Text] [Related]
10. 68Ga DOTANOC PET/CT detects medullary thyroid cancer relapse at bone level.
Nicolini S; Ambrosini V; Fantini L; Fanti S
Clin Nucl Med; 2012 Jun; 37(6):591-2. PubMed ID: 22614194
[TBL] [Abstract][Full Text] [Related]
11. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results.
Ambrosini V; Zompatori M; De Luca F; Antonia D; Allegri V; Nanni C; Malvi D; Tonveronachi E; Fasano L; Fabbri M; Fanti S
J Nucl Med; 2010 Dec; 51(12):1950-5. PubMed ID: 21078794
[TBL] [Abstract][Full Text] [Related]
12. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of somatostatin receptor PET/CT using 68Ga-DOTANOC in gastrinoma patients with negative or equivocal CT findings.
Naswa N; Sharma P; Soundararajan R; Karunanithi S; Nazar AH; Kumar R; Malhotra A; Bal C
Abdom Imaging; 2013 Jun; 38(3):552-60. PubMed ID: 22743840
[TBL] [Abstract][Full Text] [Related]
14. 68Ga-DOTANOC PET/CT imaging in glomus laryngicum.
Sharma P; Dhull VS; Bal C; Malhotra A; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):379-80. PubMed ID: 23877522
[TBL] [Abstract][Full Text] [Related]
15. Metastatic melanoma to the thyroid gland expressing somatostatin receptors-imaging with 68Ga-DOTANOC PET/CT.
Jung RS; Mittal BR; Bal A; Dey P; Shukla J; Kapoor R
Clin Nucl Med; 2015 Feb; 40(2):175-6. PubMed ID: 25546189
[TBL] [Abstract][Full Text] [Related]
16. 68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease.
Ambrosini V; Campana D; Allegri V; Opocher G; Fanti S
Clin Nucl Med; 2011 Jan; 36(1):64-5. PubMed ID: 21157217
[TBL] [Abstract][Full Text] [Related]
17. Normal uptake of 68Ga-DOTA-TOC by the pancreas uncinate process mimicking malignancy at somatostatin receptor PET.
Jacobsson H; Larsson P; Jonsson C; Jussing E; Grybäck P
Clin Nucl Med; 2012 Apr; 37(4):362-5. PubMed ID: 22391705
[TBL] [Abstract][Full Text] [Related]
18. Ectopic pituitary adenoma with empty sella in the setting of MEN-1 syndrome: detection with 68Ga-DOTANOC PET/CT.
Naswa N; Das CJ; Sharma P; Karunanithi S; Bal C; Kumar R
Jpn J Radiol; 2012 Nov; 30(9):783-6. PubMed ID: 22923184
[TBL] [Abstract][Full Text] [Related]
19. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.
Wild D; Mäcke HR; Waser B; Reubi JC; Ginj M; Rasch H; Müller-Brand J; Hofmann M
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):724. PubMed ID: 15551131
[No Abstract] [Full Text] [Related]
20. Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDG.
Jain S; Sharma P; Dhull VS; Bal C; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):358-9. PubMed ID: 24217543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]